Kansas City, Missouri 2021-06-10 09:00:50 –
Modana He states that he has submitted an application for an emergency use authorization for the COVID-19 vaccine for use in adolescents aged 12 to 18 years.
The company’s application is for a double vaccination 100% effective A Phase 2/3 study of nearly 2,500 adolescents prevented COVID-19. The same study found that the vaccine was 93% effective in preventing the virus two weeks after the patient received a single dose.
“We recommend that the Moderna COVID-19 vaccine was very effective in preventing COVID-19 and SARS-CoV-2 infections in adolescence,” Moderna CEO Stéphane Bancel said in a statement. The European Medicines Agency and we apply to regulators around the world for this important young age group. We continue to work to help eradicate the COVID-19 pandemic. “
If the Centers for Disease Control and Prevention and the FDA approve a request for an emergency use authorization, Moderna’s vaccine will be the second COVID-19 vaccine approved for use in adolescence. Pfizer’s COVID-19 vaccine was approved in May for children up to the age of 12.
The approval of Moderna’s COVID-19 vaccine will increase the supply of doses available to teens and allow them to be vaccinated in the summer before school reopens in the fall.
Moderna seeks emergency use authorization for use of its COVID-19 vaccine in kids as young as 12 Source link Moderna seeks emergency use authorization for use of its COVID-19 vaccine in kids as young as 12